Efficacy Evaluation of Unified Transdiagnostic Treatment in Symptoms Reduction of Patients with Generalized Anxiety Disorder and a Comorbid Emotional Disorder

In this study we examined the efficacy of Unified transdiagnostic Treatment in symptoms reduction of patients with generalized anxiety disorder and a comorbid emotional disorder. Three women with Generalized Anxiety Disorder (GAD) and a comorbid emotional disorder were selected by using purposeful sampling method; along with diagnostic interview and Structured Clinical Interview for DSM-IV (SCID) based on disorders axis I. Patients underwent the treatment process subsequent to obtaining treatment requirements. Non-congruent multiple baseline experimental single case study was used as the method of the present study.The efficacy of Unified transdiagnostic Treatment Protocol (UP) was carried out in three phase of intervention (Baseline, 12 session treatment and 6 weeks follow-up) by using the Penn State Worry Questionnaire (PSWQ), Generalized Anxiety Disorder Questionnaire (GAD-Q-IV), Positive and Negative Affect Scales (PANAS), Work and Social Adjustment Scale (WSAS) and comorbid diagnosis-specific measures evaluated. Data analyzed with visuals inspection, improvement percentage and reliable change index (RCI) strategies. Results showed Unified transdiagnostic Treatment had both clinically and statistically (p<0/05) significant efficient on the reduction of treatment's target (worry, negative affect, functioning impairment and symptoms of GAD and comorbid disorder) severity. Unified transdiagnostic Treatment has appropriate efficacy in the symptoms reduction of patients suffering from Generalized Anxiety Disorder with a comorbid emotional disorder.